For Patients and Caregivers What to Expect When Taking Riabni™

A FEW THINGS TO KEEP IN MIND AS YOU START RIABNI™

How to take RIABNI™

RIABNI™ is given as an infusion. You may be prescribed RIABNI™ alone or with chemotherapy. The treatment schedule for RIABNI™ depends on the type of B-cell NHL or CLL you have. Your doctor or nurse will discuss which combination of treatments is right for you.1

4-6-hors 4-6-hors

The first infusion of RIABNI™ is given slowly over
4 to 6 hours or longer to lessen the chance of a reaction. If you have an infusion-related reaction, your infusion will be slowed or stopped.1

90-mins 90-mins

The next infusions should be shorter, lasting 3 to 4 hours or even just 90 minutes. Not all patients will be able to receive a faster infusion. It depends on your disease and how your body reacted to your last infusion.1

During and after RIABNI™ treatment

Tell your healthcare provider, or get medical help right away, if you notice any of these symptoms during or after your RIABNI™ infusion:2

clipboard-icon
  • Hives (itchy red welts) or rash
  • Itching
  • Swelling of your lips, tongue, throat, or face
  • Sudden cough
  • Shortness of breath, difficulty breathing, or wheezing
  • Weakness
  • Dizziness or feeling faint
  • Palpitations (feeling like your heart is racing or fluttering)
  • Chest pain

Be sure to review the Prescribing Information to learn more about potential side effects and symptoms.

image description

If you feel unwell during your treatment, please tell your treatment team

image description

What if my doctor switches me from Rituxan®, OR ANOTHER RITUXIMAB BIOSIMILAR, to RIABNI™?

RIABNI™ was proven to be similar to Rituxan® in safety and effectiveness.3

The FDA sets rigorous standards for making and approving biosimilars, so you can feel confident relying on the safety and effectiveness of RIABNI™, just as you would with Rituxan® or your other biosimilar medication.4

Table name here
  RIABNI™1 Rituxan®2
EFFECTIVENESS
SAFETY
DOSING & ADMINISTRATION

See support and resources available
to patients taking RIABNI™

More